Abstract
p38 Mitogen-activated protein kinase (MAPK) has been considered to be a promising target for the development of therapeutics for various immunologic diseases. Herein we report an example for a successful application of the virtual screening with protein-ligand docking to identify the novel inhibitors of p38α MAPK. These inhibitors were screened for having desirable physicochemical properties as a drug candidate and compound 1-3 revealed a moderate inhibitory activity with IC 50 values ranging from 0.7 to 20 μM. Therefore, they deserve a consideration for further development by structure-activity relationship (SAR) studies to optimize the inhibitory activities. Structural features relevant to the stabilization of the newly identified inhibitors in the ATP-binding site of p38 MAPK are addressed in detail.
| Original language | English |
|---|---|
| Pages (from-to) | 2195-2199 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 22 |
| Issue number | 6 |
| DOIs | |
| State | Published - 15 Mar 2012 |
Bibliographical note
Funding Information:This research was supported by National Research Foundation of Korea (NRF) through general research grants ( NRF-2011-0003609 , 2011-0016436 ) and 2011-0020322 .
Keywords
- Anti-inflammatory agents
- Docking
- Inhibitor
- Virtual screening
- p38 MAPK